IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Tuberculosis (TB) is a chronic disease caused by Mycobacterium tuberculosis.
• T cell dysfunction and exhaustion are observed in severe TB, potentially leading to treatment failure.
• The mechanisms underlying T cell dysfunction in TB remain unclear.

Purpose of the Study:

• To establish a mouse model of T cell dysfunction induced by persistent M. tuberculosis antigen stimulation.
• To investigate the therapeutic potential of interleukin-2 (IL-2) in restoring T cell function and protective immunity.

Main Methods:

• C57BL/6 mice were immunized with Mycobacterium bovis Bacillus Calmette-Guérin (BCG).
• Mice received repeated boosts with M. tuberculosis antigens (fusion proteins or specific antigens with adjuvants) to induce persistent stimulation.
• T cell dysfunction was assessed by measuring cytokine production (IFN-γ, IL-2), CD8+ T cell memory populations, and immune checkpoint protein expression (PD-1).
• Therapeutic intervention involved treating T cell-exhausted mice with IL-2, followed by analysis of immune responses and protective efficacy against bacterial challenge.

Main Results:

• Persistent M. tuberculosis antigen stimulation led to decreased antigen-specific IFN-γ and IL-2 production.
• Reduced memory CD8+ T cell populations and over-expression of PD-1 were observed in persistently stimulated mice.
• This persistent stimulation impaired protective immunity against bacterial challenge.
• IL-2 treatment successfully restored antigen-specific T cell responses and protective efficacy in functionally exhausted mice.

Conclusions:

• Persistent stimulation with M. tuberculosis antigens induces T cell dysfunction and exhaustion.
• IL-2 therapy can restore T cell responses and protective immunity in this model of TB-induced T cell dysfunction.